These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38795847)

  • 21. Combining Network Pharmacology, Molecular Docking and Preliminary Experiments to Explore the Mechanism of Action of FZKA Formula on Non-small Cell Lung Cancer.
    Liu Z; Zhang J; Liu J; Guo L; Chen G; Fang Y; Yang Y
    Protein Pept Lett; 2023; 30(12):1038-1047. PubMed ID: 37962044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of Colorectal Cancer based on Network Pharmacology and Bioinformatics Validation.
    Wang T; Zhang W; Fang C; Wang N; Zhuang Y; Gao S
    Curr Comput Aided Drug Des; 2024; 20(5):486-500. PubMed ID: 37287284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Network module analysis and molecular docking-based study on the mechanism of astragali radix against non-small cell lung cancer.
    Xiao W; Xu Y; Baak JP; Dai J; Jing L; Zhu H; Gan Y; Zheng S
    BMC Complement Med Ther; 2023 Sep; 23(1):345. PubMed ID: 37770919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a novel protein kinase C activator from Croton tiglium for inhibition of non-small cell lung cancer.
    Wang Y; Tang C; Yao S; Lai H; Li R; Xu J; Wang Q; Fan XX; Wu QB; Leung EL; Ye Y; Yao X
    Phytomedicine; 2019 Dec; 65():153100. PubMed ID: 31648127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating GEO, network pharmacology, and in vitro assays to explore the pharmacological mechanism of Bruceae Fructus against laryngeal cancer.
    Wu Z; Zhu Z; Fu L
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4165-4181. PubMed ID: 38032489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
    Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
    BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploration in the mechanism of fucosterol for the treatment of non-small cell lung cancer based on network pharmacology and molecular docking.
    Li X; Lin B; Lin Z; Ma Y; Wang Q; Zheng Y; Cui L; Luo H; Luo L
    Sci Rep; 2021 Mar; 11(1):4901. PubMed ID: 33649481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Explore the mechanism and substance basis of Mahuang FuziXixin Decoction for the treatment of lung cancer based on network pharmacology and molecular docking.
    Zhang W; Tian W; Wang Y; Jin X; Guo H; Wang Y; Tang Y; Yao X
    Comput Biol Med; 2022 Dec; 151(Pt A):106293. PubMed ID: 36399857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments.
    Peng H; Huang Z; Li P; Sun Z; Hou X; Li Z; Sang R; Guo Z; Wu S; Cao Y
    J Ethnopharmacol; 2024 Mar; 321():117518. PubMed ID: 38042385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Casticin and chrysosplenol D from Artemisia annua L. induce apoptosis by inhibiting topoisomerase IIα in human non-small-cell lung cancer cells.
    Fu C; Zhang K; Wang M; Qiu F
    Phytomedicine; 2022 Jun; 100():154095. PubMed ID: 35398735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Licochalcone B inhibits growth and induces apoptosis of human non-small-cell lung cancer cells by dual targeting of EGFR and MET.
    Oh HN; Lee MH; Kim E; Yoon G; Chae JI; Shim JH
    Phytomedicine; 2019 Oct; 63():153014. PubMed ID: 31323446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma.
    Li X; Zhou M; Chen W; Sun J; Zhao Y; Wang G; Wang B; Pan Y; Zhang J; Xu J
    BMC Complement Med Ther; 2024 May; 24(1):208. PubMed ID: 38816744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: A transcriptomics/ bio-informatics biological validation approach.
    Tan HY; Ho VW; Chan YT; Zhang C; Wang N; Xia W; Feng Y
    Pharmacol Res; 2020 May; 155():104415. PubMed ID: 31465829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Network pharmacology‑based investigation of potential targets of triptonodiol acting on non-small-cell lung cancer.
    Jin F; Ni X; Yu S; Jiang X; Zhou J; Mao D; Liu Y; Wu F
    Eur J Med Res; 2023 Nov; 28(1):547. PubMed ID: 38017514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying the Multitarget Pharmacological Mechanism of Action of Genistein on Lung Cancer by Integrating Network Pharmacology and Molecular Dynamic Simulation.
    Das R; Woo J
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target Identification of 22-(4-Pyridinecarbonyl) Jorunnamycin A, a Tetrahydroisoquinoline Derivative from the Sponge
    Iksen I; Sinsook S; Wattanathamsan O; Buaban K; Chamni S; Pongrakhananon V
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gefitinib Induces Apoptosis in NSCLC Cells by Promoting Glutaminolysis and Inhibiting the MEK/ERK Signaling Pathway.
    Zhang Y; Liu H; Liu X; Lang L
    Discov Med; 2024 Apr; 36(183):836-841. PubMed ID: 38665031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines.
    Koshimune R; Aoe M; Toyooka S; Hara F; Ouchida M; Tokumo M; Sano Y; Date H; Shimizu N
    BMC Cancer; 2007 Jan; 7():8. PubMed ID: 17222343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HJC0152 suppresses human non-small-cell lung cancer by inhibiting STAT3 and modulating metabolism.
    Lu L; Li H; Wu X; Rao J; Zhou J; Fan S; Shen Q
    Cell Prolif; 2020 Mar; 53(3):e12777. PubMed ID: 32022328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yi Qi Chu Tan Formula (YQCTF) inhibited the progress of lung cancer via regulating tumor-associated neutrophil: An integrated study of network pharmacology, proteomics and pharmacodynamics.
    Le-Xin C; Ming-Jun L; Chun-Qi X; Jia-Xin Z; Jing-Ya Y; Li-Xin N; Mei-Qi W; En-Xin Z; Xiao-Jun Z
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116943. PubMed ID: 37532072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.